BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Clin Cases. Nov 16, 2025; 13(32): 110553
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.110553
Table 3 Primary and secondary outcomes, n (%)
Variables
AC with ABP, n = 90
AC without ABP, n = 268
P value
Overall population(n = 90)(n = 268)
    ICU admission6 (6.7)12 (4.5)0.411
    30-day mortality1 (1.1)1 (0.4%)0.416
    LOHS in days7.0 (5.5-9.5)7.0 (5.0-9.0)0.554
    30-day readmission8 (8.9)18 (6.7)0.492
Mild AC(n = 39)(n = 141)
    ICU admission00
    30-day mortality00
    LOHS in days6.0 (5.0-8.0)6.0 (5.0-8.0)0.823
    30-day readmission4 (10.2)5 (3.5)0.097
Moderate AC(n = 28)(n = 71)
    ICU admission00
    30-day mortality00
    LOHS in days6.0 (5.0-8.5)6.0 (5.0-9.0)0.666
    30-day readmission1 (3.6)7 (9.9)0.301
Severe AC(n = 23)(n = 56)
    ICU admission6 (26.0)12 (21.4)0.201
    30-day mortality3 (13.0)6 (10.7)0.510
    LOHS in days9.0 (7.0-10.5)7.5 (6.0-11.0)0.409
    30-day readmission3 (13.0)6 (10.7)0.767


Write to the Help Desk